Heron Therapeutics Inc (HRTX) Net earnings per share growth forecast for next year

Corporate company logo of Heron Therapeutics, Inc. (HRTX)

The recruitment of top-tier oncology and pain therapy specialists has served as a growth catalyst for Heron Therapeutics (HRTX). The historical trend of next year's EPS forecasts on the GURU.Markets time chart confirms this trajectory, where the 11.30 level reflects the current magnitude. This has enabled the establishment of strict temperature control during drug delivery and the complete transition of production to external outsourcing.

Heron Therapeutics Inc (HRTX): Net earnings per share growth forecast for next year from 07/04/2022 to 11/18/2026

Summary analytical data breakdowns for Heron Therapeutics (HRTX)

- share price and consensus valuation forecast:
Fundamental company analysis:Heron
Finished products of Heron Therapeutics Inc

To assess the long-term risks of Heron Therapeutics (HRTX), the earnings per share growth forecast, which reflects analyst consensus expectations for future returns, is critically important. This indicator measures the expected EPS dynamics, stripping fundamental value from market speculation. By analyzing the trend of earnings per share growth forecasts, an investor can discern the speed at which the business adapts to new challenges. The stability of the healthcare sector and a neutral geopolitical backdrop support the resilience of this metric.

Competitor analysis for Heron Therapeutics

INCY (incyte.com) - Earnings growth forecast for next year|Expected net earnings per share growth next year hutch-med.com HCM|Net earnings per share growth forecast for next year Nuvation Corp (NUVB)|DAWN - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Monopar Pharma MNPR|Inhibrx Corp - Net earnings per share growth forecast for next year|IMAB - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Fennec Pharmaceuticals|NVCT: Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Coherus CHRS|Expected earnings per share growth for next year CRBP|Expected net earnings per share growth next year Cardiff Oncology CRDF|Expected earnings per share growth for next year BYSI (BeyondSpring Inc.)|BCAB (BioAtla Corp) - Expected earnings per share trend next year|Lixte Biotechnology - Expected earnings per share growth for next year|Projected earnings per share increase next year CTXR (Citius Pharma)|Cellectar - Earnings growth forecast for next year|Expected earnings per share trend next year BLRX (BioLineRx Corp)|CANF: Earnings growth forecast for next year|Expected net earnings per share growth next year Aprea (APRE)|Net earnings per share growth forecast for next year kaziatherapeutics.com|SLXN: Expected earnings per share trend next year|Earnings growth forecast for next year NCNA|Earnings growth forecast for next year Chimerix Inc (CMRX)|Net earnings per share growth forecast for next year Cyclacel Pharmaceuticals Inc. CYCC|GTHX (g1therapeutics.com) - Net earnings per share change forecast for next year|KRON: Expected earnings per share growth for next year|Expected net earnings per share growth next year Kintara Therapeutics Inc|oncternal.com (ONCT) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year PRTG (Portage Biotech Corp)